Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance.

Chatterton H, Younger T, Fischer A, Khunti K; Programme Development Group.

BMJ. 2012 Jul 12;345:e4624. doi: 10.1136/bmj.e4624. No abstract available.

PMID:
22791792
2.

Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.

Goldberg RB, Mather K.

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2077-90. doi: 10.1161/ATVBAHA.111.241893. Review.

3.

Therapeutic Challenges in Diabetes Prevention: We Have Not Found the "Exercise Pill".

Srinivasan S, Florez JC.

Clin Pharmacol Ther. 2015 Aug;98(2):162-9. doi: 10.1002/cpt.146. Epub 2015 Jun 25. Review.

4.

Clinical Inquiry: Does metformin prevent diabetes in at-risk adults?

Mangahas T, Huang G, Neher J, Safranek S.

J Fam Pract. 2013 Aug;62(8):436-7. Review. No abstract available.

PMID:
24143338
5.

RCPE UK consensus statement on diabetes.

Anderson A, Boyd K, Christie B, Claridge C, Currie P, Doherty T, Dorward D, Elder A, Hadley-Brown M, Hughes D, Jackson M, Jung R, Marshall S, MacKinnon M, Pollock A, Ritchie L.

J R Coll Physicians Edinb. 2010 Jun;40(2):130-1. doi: 10.4997/JRCPE.2010.S06. No abstract available.

PMID:
21125057
6.

The nurse's role in discouraging clinical inertia in diabetes management: optimizing cardiovascular health among African-Americans.

Appel SJ, Giger JN.

J Natl Black Nurses Assoc. 2007 Dec;18(2):vii-viii. Review. No abstract available.

PMID:
18318325
7.

Metformin as a weight-loss tool in "at-risk" obese adolescents: a magic bullet?

Kasa-Vubu JZ.

J Pediatr. 2008 Jun;152(6):750-2. doi: 10.1016/j.jpeds.2008.03.006. Review. No abstract available.

PMID:
18492507
8.

Improving glycemic control and cardiometabolic risk through integrated treatment plans.

Lavernia F.

J Am Osteopath Assoc. 2010 Jul;110(7 Suppl 7):eS13-9. Review.

PMID:
20644200
9.

Metformin for prevention of type 2 diabetes.

Hess AM, Sullivan DL.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1283-5. Epub 2004 May 18. Review.

PMID:
15150378
10.

[Prevention of type 2 diabetes mellitus].

Palitzsch D, Bührlen M.

MMW Fortschr Med. 2012 May 16;154(9):45-8. Review. German. No abstract available.

PMID:
22715631
11.

FPIN's clinical inquiries. Metformin therapy and diabetes prevention in adolescents who are obese.

Rodríguez JE, Shearer B, Slawson DC.

Am Fam Physician. 2007 Nov 1;76(9):1357-8. Review. No abstract available.

12.

Treating to target: implementing an effective diabetes care paradigm for managed care.

Berger JE, Ahmann AJ, Balfour DC, Owens GS, Beltran R, Bush MA, Culpepper L, Owens GS, Ringel M, Welty FK.

Am J Manag Care. 2010 Mar;16 Suppl Treating:S4-35. Review. No abstract available.

13.

Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review.

Bennett WL, Odelola OA, Wilson LM, Bolen S, Selvaraj S, Robinson KA, Bass EB, Puhan MA.

Ann Intern Med. 2012 Jan 3;156(1 Pt 1):27-36. doi: 10.7326/0003-4819-156-1-201201030-00005. Review.

PMID:
22213492
14.

[Is it possible to prevent type 2 diabetes?].

Laville M.

Ann Endocrinol (Paris). 2003 Jun;64(3 Suppl):S37-44. Review. French.

PMID:
12910058
15.

Type 2 diabetes mellitus in children and youth.

Ramkumar S, Tandon N.

Indian J Pediatr. 2013 Mar;80 Suppl 1:S87-94. doi: 10.1007/s12098-013-0962-6. Epub 2013 Feb 21. Review.

PMID:
23430571
16.
17.

Is an SGLT2 inhibitor right for your patient with type 2 diabetes?

Lisenby KM, Meyer A, Slater NA.

J Fam Pract. 2016 Sep;65(9):587-93. Review.

PMID:
27672684
18.

Metformin: the past, presence, and future.

Alušík Š, Paluch Z.

Minerva Med. 2015 Aug;106(4):233-8. Epub 2014 Dec 23. Review.

PMID:
25532538
19.
20.

Managing type 2 diabetes: new policy and interventions.

Gillibrand W, Holdich P, Covill C.

Br J Community Nurs. 2009 Jul;14(7):285, 288-91. Review.

PMID:
19597379

Supplemental Content

Support Center